Legal Representation
Attorney
Nancy Sabarra
USPTO Deadlines
Next Deadline
148 days remaining
NOA E-Mailed - SOU Required
Due Date
May 16, 2026
Application History
41 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 20, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Nov 19, 2025 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Nov 16, 2025 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Nov 17, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 14, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 14, 2025 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| May 13, 2025 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| May 13, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 6, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 5, 2025 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Nov 18, 2024 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Feb 5, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Nov 18, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 15, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 14, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| May 14, 2024 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| May 14, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 17, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Nov 15, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Nov 15, 2023 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Nov 15, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 16, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Mar 21, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Mar 21, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 1, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Feb 15, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 14, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 13, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 13, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jan 20, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jan 20, 2023 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Jan 20, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Nov 23, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Nov 23, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Nov 23, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| May 27, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| May 27, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| May 27, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 23, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 7, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 24, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
vaccines; vaccines for human use; flu vaccines
Class 042
Scientific research in the nature of conducting clinical trials for pharmaceutical preparations; scientific research in the nature of conducting clinical trials for flu vaccines; providing clinical trial research information about the results of clinical trials for flu vaccines; providing medical research and scientific research information in the field of flu vaccines and flu vaccine clinical trials; pharmaceutical research and development
Class 044
Medical information; pharmaceutical information, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical information services in the field of pharmaceuticals for preventing and treating viruses and respiratory disorders, including vaccines and pharmaceutical therapeutics
Classification
International Classes
005
042
044